Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effect of dapagliflozin on obstructive sleep apnea in patients with type 2 diabetes: a preliminary study
Yi Tang, Qin Sun, Xiaoyan Bai, et al.
Nutrition and Diabetes (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 57

Showing 26-50 of 57 citing articles:

New acridine-9-carboxamide linked to 1,2,3-triazole-N-phenylacetamide derivatives as potent α-glucosidase inhibitors: design, synthesis, in vitro, and in silico biological evaluations
Nima Sepehri, Nafise Asemanipoor, Seyed Ali Mousavianfard, et al.
Medicinal Chemistry Research (2020) Vol. 29, Iss. 10, pp. 1836-1845
Closed Access | Times Cited: 20
Heart Failure with Preserved Ejection Fraction and Obstructive Sleep Apnea: A Novel Paradigm for Additional Cardiovascular Benefit of SGLT2 Inhibitors in Subjects With or Without Type 2 Diabetes
Vincenzo Maria Monda, Sandro Gentile, Francesca Porcellati, et al.
Advances in Therapy (2022) Vol. 39, Iss. 11, pp. 4837-4846
Open Access | Times Cited: 12
The benefits of hypoglycemic therapy for patients with obstructive sleep apnea
Ruihan Lin, Wenjie Yan, He Meng, et al.
Sleep And Breathing (2024) Vol. 28, Iss. 3, pp. 1355-1363
Closed Access | Times Cited: 2
Empagliflozin therapy and insulin resistance-associated disorders: effects and promises beyond a diabetic state
Georgios S. Papaetis
Archives of Medical Science - Atherosclerotic Diseases (2021) Vol. 6, Iss. 1, pp. 57-78
Open Access | Times Cited: 15
The impact of sodium-glucose Cotransporter-2 inhibitors on lipid profile: A meta-analysis of 28 randomized controlled trials
Gang Fan, Dian long Guo, Hong Zuo
European Journal of Pharmacology (2023) Vol. 959, pp. 176087-176087
Closed Access | Times Cited: 6
Basic and Clinical Pharmaco-Therapeutics of SGLT2 Inhibitors: A Contemporary Update
Sanjay Kalra, Kimi Shetty, Vertivel B. Nagarajan, et al.
Diabetes Therapy (2020) Vol. 11, Iss. 4, pp. 813-833
Open Access | Times Cited: 13
Prediabetes Is Associated with Increased Prevalence of Sleep-Disordered Breathing
Enric Sánchez, Esther Sapiña-Beltrán, Ricard Gavaldà, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 5, pp. 1413-1413
Open Access | Times Cited: 9
Effect of Glucose Improvement on Nocturnal Sleep Breathing Parameters in Patients with Type 2 Diabetes: The Candy Dreams Study
Liliana Gutiérrez-Carrasquilla, Carolina López‐Cano, Enric Sánchez, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 4, pp. 1022-1022
Open Access | Times Cited: 12
New 4,5-diphenylimidazole-acetamide-1,2,3-triazole hybrids as potent α-glucosidase inhibitors: synthesis, in vitro and in silico enzymatic and toxicity evaluations
Nima Sepehri, Homa Azizian, Reza Ghadimi, et al.
Monatshefte für Chemie - Chemical Monthly (2021) Vol. 152, Iss. 6, pp. 679-693
Closed Access | Times Cited: 11
Efficacy of dapagliflozin in the treatment of HFrEF with obstructive sleep apnea syndrome (DAHOS study): study protocol for a multicentric, prospective, randomized controlled clinical trial
Liang Xie, Songsong Song, Shengnan Li, et al.
Trials (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Sleep-disordered breathing and heart failure: a vicious cycle of cardiovascular risk
Fulvio Cacciapuoti, Antonio D’Onofrio, Luca Gaetano Tarquinio, et al.
Monaldi Archives for Chest Disease (2023)
Open Access | Times Cited: 4
Beyond the Glycaemic Control of Dapagliflozin: Microangiopathy and Non-classical Complications
Virginia Bellido, Julia Martı́nez, F. L. Calvo, et al.
Diabetes Therapy (2022) Vol. 13, Iss. 5, pp. 873-888
Open Access | Times Cited: 7
The effect of dapagliflozin on myocardial ischemia–reperfusion injury in diabetic rats
Shilong Xiong, Donghua Mo, Yingjun Wu, et al.
Canadian Journal of Physiology and Pharmacology (2023) Vol. 101, Iss. 2, pp. 80-89
Closed Access | Times Cited: 3
Dapagliflozin initiation in chronic heart failure patients improves central sleep apnoea
Dany Jaffuel, Yannick Bouchaut, Jean‐Pierre Mallet, et al.
ERJ Open Research (2023) Vol. 9, Iss. 3, pp. 00123-2023
Open Access | Times Cited: 3
Comment on Sodium-Glucose Co-Transporter 2 Inhibitors and Heart Failure
Erkan Cüre, Medine Cumhur Cüre
The American Journal of Cardiology (2020) Vol. 125, Iss. 10, pp. 1602-1602
Closed Access | Times Cited: 8
SGLT2 inhibitors and sleep apnea; how helpful are the medications: A meta-analysis
Tanveer Mir, Hassan Bin Atique, Neelambuj Regmi, et al.
Endocrine and Metabolic Science (2021) Vol. 2, pp. 100084-100084
Open Access | Times Cited: 7
Athrixia phylicoides tea infusion (bushman tea) improves adipokine balance, glucose homeostasis and lipid parameters in a diet-induced metabolic syndrome rat model
Madigoahle A. M. Mokwena, Godwill Azeh Engwa, Benedicta N. Nkeh-Chungag, et al.
BMC Complementary Medicine and Therapies (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 7
Could Dapagliflozin Attenuate COVID-19 Progression in High-Risk Patients With or Without Diabetes? Behind DARE-19 Concept
Georgia Anastasiou, Erifili Hatziagelaki, Evangelos Liberopoulos
Journal of Cardiovascular Pharmacology (2021) Vol. 78, Iss. 1, pp. e12-e19
Open Access | Times Cited: 6
The effects of dietary/herbal supplements and the serum levels of micronutrients on the healing of diabetic foot ulcers in animal and human models: a systematic review
Mohammad Reza Amini, Maryam Aalaa, Ensieh Nasli‐Esfahani, et al.
Journal of Diabetes & Metabolic Disorders (2021) Vol. 20, Iss. 1, pp. 973-988
Open Access | Times Cited: 6
Preparation, structural characteristics and physiological property of resistant starch
Rui Wang, Mei Li, Pádraig Strappe, et al.
Advances in food and nutrition research (2021), pp. 1-40
Closed Access | Times Cited: 4
Relationship between obstructive sleep apnea and type 2 diabetes mellitus
Romina Abelleira, Carlos Zamarrón, Vanessa Riveiro, et al.
Medicina Clínica (English Edition) (2024) Vol. 162, Iss. 8, pp. 363-369
Closed Access
SGLT2 Inhibitors in COVID-19: Umbrella Review, Meta-analysis, and Bayesian Sensitivity Assessment
Vinay Suresh, Muhammad Aaqib Shamim, Victor Ghosh, et al.
Research Square (Research Square) (2024)
Open Access
Cardiovascular disease and sleep apnea in patients with type 2 diabetes mellitus
O.M. Koteshkova Koteshkova, М. Б. Анциферов, D.M. Antsiferova, et al.
Meditsinskiy sovet = Medical Council (2024), Iss. 6, pp. 64-71
Open Access
Update on the clinical applications of SGLTis: Insight to benefits beyond hypoglycemic and cardiorenal protection
Shibing Tao, S. Guo, Nanwei Tong
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2024) Vol. 44, Iss. 8, pp. 642-657
Closed Access
Impact of Obstructive Sleep Apnea in Patients with Acute Heart Failure: A Nationwide Cohort Study
Abdulmajeed Alharbi, Nahush Bansal, Anas Alsughayer, et al.
Hearts (2024) Vol. 5, Iss. 4, pp. 547-556
Open Access

Scroll to top